Ahmadreza Zarifian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ahmadreza Zarifian has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Sobhan Sheikh Andalibi
Department of Neurosciences, University of California San Diego, San Diego, CA 92093, USA
5 shared publications - Parisa Zafari
Mazandaran University of Medical Sciences, Iran
3 shared publications - Saphalya Pattnaik
Trauma and Orthopaedics, University Hospital Lewisham, London, GBR
3 shared publications - Shahid Punwar
Trauma and Orthopaedics, University Hospital Lewisham, London, GBR
3 shared publications - Alireza Rafiei
Department of Immunology, Molecular and Cell Biology Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
2 shared publications Gordon A. Ferns
Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex BN1 9PH, UK
2 shared publications
Latest Publications
- Open Access
- 12 October 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (10)
Aseptic Meningitis as First Presentation of Acute Myeloid Leukemia With Normal Cell Blood Count
Aseptic meningitis can be the initial manifestation of acute myeloid leukemia (AML), even when the complete blood count (CBC) is normal. A single cerebrospinal fluid (CSF) analysis for malignant cells may be insufficient and could delay diagnosis. Therefore, infections, collagen vascular diseases, and malignancies—particularly leukemias—should be carefully considered.
- 12 October 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (10)
Open AccessAseptic Meningitis as First Presentation of Acute Myeloid Leukemia With Normal Cell Blood Count
Aseptic meningitis can be the initial manifestation of acute myeloid leukemia (AML), even when the complete blood count (CBC) is normal. A single cerebrospinal fluid (CSF) analysis for malignant cells may be insufficient and could delay diagnosis. Therefore, infections, collagen vascular diseases, and malignancies—particularly leukemias—should be carefully considered.
- Open Access
- 26 November 2023
- Published by Springer Nature in Cureus
- Vol. 15 (11) , e49434
Improving Completion Rates of Treatment Escalation Plan (TEP) in a London Teaching Hospital: A Quality Improvement Study
Background Treatment escalation plans (TEPs) provide enhanced clarity in planning appropriate decision-making in the management of deteriorating patients by explicitly defining a limit of care. These decisions are discussed with patients or their relatives and mutually agreed upon. We aimed to improve staff adherence to the completion of TEPs upon the admission of patients to the orthopedics wards in a London teaching hospital. Methods This study employed the Plan-Do-Study-Act (PDSA) methodology to investigate the efficacy of interventions implemented within a hospital setting for adult inpatients receiving orthopedic treatment. The approach adopted was cross-sectional, where a comprehensive audit was conducted on all adult inpatients admitted to the hospital. The initial cycle of the study was conducted in March 2022, followed by the implementation of interventions in the form of an internal algorithm. Subsequently, the second cycle of the study was conducted in November 2022. Results We sampled a total of 50 patients (PDSA 1, n=27; PDSA 2, n=23). Following the implementation of a designated local TEP pathway, the proportion of patients with incomplete TEPs fell from 30.4% (n=7, PDSA Cycle 1) to 11.76% (n=2, PDSA Cycle 2). Conclusions The study has demonstrated that interventions such as institutional algorithms and departmental meetings can be useful in improving the adherence of staff to complete TEPs. Ongoing training and education can help overcome some of the barriers to TEP completion.
- 26 November 2023
- Published by Springer Nature in Cureus
- Vol. 15 (11) , e49434
Open AccessImproving Completion Rates of Treatment Escalation Plan (TEP) in a London Teaching Hospital: A Quality Improvement Study
Background Treatment escalation plans (TEPs) provide enhanced clarity in planning appropriate decision-making in the management of deteriorating patients by explicitly defining a limit of care. These decisions are discussed with patients or their relatives and mutually agreed upon. We aimed to improve staff adherence to the completion of TEPs upon the admission of patients to the orthopedics wards in a London teaching hospital. Methods This study employed the Plan-Do-Study-Act (PDSA) methodology to investigate the efficacy of interventions implemented within a hospital setting for adult inpatients receiving orthopedic treatment. The approach adopted was cross-sectional, where a comprehensive audit was conducted on all adult inpatients admitted to the hospital. The initial cycle of the study was conducted in March 2022, followed by the implementation of interventions in the form of an internal algorithm. Subsequently, the second cycle of the study was conducted in November 2022. Results We sampled a total of 50 patients (PDSA 1, n=27; PDSA 2, n=23). Following the implementation of a designated local TEP pathway, the proportion of patients with incomplete TEPs fell from 30.4% (n=7, PDSA Cycle 1) to 11.76% (n=2, PDSA Cycle 2). Conclusions The study has demonstrated that interventions such as institutional algorithms and departmental meetings can be useful in improving the adherence of staff to complete TEPs. Ongoing training and education can help overcome some of the barriers to TEP completion.
- Open Access
- 28 October 2023
- Published by Springer Nature in Cureus
- Vol. 15 (10) , e47857
Navigating ACL Injuries Amid the COVID-19 Pandemic: A Retrospective Analysis
Introduction In the United Kingdom, musculoskeletal injuries represent a substantial proportion of primary care appointments, and within this category, acute knee injuries are prominent in accident and emergency department cases. Notably, diagnosing anterior cruciate ligament (ACL) injuries is a recognized challenge, often leading to extended diagnostic delays. The COVID-19 pandemic has significantly affected the management of musculoskeletal disorders, driven by reduced surgical capacities, creating a backlog of patients awaiting necessary surgical interventions. Delayed ACL reconstruction poses risks of prolonged knee instability and secondary injuries. To address these concerns, this study evaluates the impact of COVID-19 on the timeline from ACL injury diagnosis to MRI and surgical intervention, with a specific focus on an internal acute knee clinic pathway designed to expedite the evaluation, diagnosis, and management of soft tissue knee injuries. Methods In this cross-sectional study, we retrospectively reviewed all the patients who underwent primary ACL reconstruction from January 2019 to November 2022 in a district general teaching hospital (DGH). Besides demographic data of the patients, we recorded the dates of injury, primary presentation, first knee specialist review, knee MRI, and ACL reconstruction surgery, as well as the injury-to-surgery, injury-to-MRI, and MRI-to-surgery periods. Patients were divided based on the date of operation to pre- and post-COVID, and outcomes were compared to see the possible effects of COVID-19. Data were analyzed using a quantitative and qualitative test with a P < 0.05 significance level. Results Our cohort included 97 patients, and the mean age of patients was 30.6 years (17-53 years). The median time of injury-to-MRI was 46.5 days during the pre-COVID period, which decreased to 44 days in the post-COVID period (P = 0.596). The median time of injury-to-surgery was 287.5 days during the pre-COVID period, which increased to 289 days in the post-COVID period (P = 0.019). The median MRI-to-surgery duration was 200 days during the pre-COVID period, which increased to 225 days in the post-COVID period (P = 0.006). Around 35% of patients had an MRI prior to getting evaluated by a specialist. Conclusion The COVID-19 pandemic had a significant impact on the management of ACL injuries, with delays in elective knee clinics and surgery potentially leading to delays in the diagnosis and management of such injuries. However, our study showed that the delay from ACL injury to subsequent surgery actually reduced post-pandemic due to hospital-based acute knee pathway, which is particularly important in the context of associated meniscal injury that can worsen while patients wait for surgery.
- 28 October 2023
- Published by Springer Nature in Cureus
- Vol. 15 (10) , e47857
Open AccessNavigating ACL Injuries Amid the COVID-19 Pandemic: A Retrospective Analysis
Introduction In the United Kingdom, musculoskeletal injuries represent a substantial proportion of primary care appointments, and within this category, acute knee injuries are prominent in accident and emergency department cases. Notably, diagnosing anterior cruciate ligament (ACL) injuries is a recognized challenge, often leading to extended diagnostic delays. The COVID-19 pandemic has significantly affected the management of musculoskeletal disorders, driven by reduced surgical capacities, creating a backlog of patients awaiting necessary surgical interventions. Delayed ACL reconstruction poses risks of prolonged knee instability and secondary injuries. To address these concerns, this study evaluates the impact of COVID-19 on the timeline from ACL injury diagnosis to MRI and surgical intervention, with a specific focus on an internal acute knee clinic pathway designed to expedite the evaluation, diagnosis, and management of soft tissue knee injuries. Methods In this cross-sectional study, we retrospectively reviewed all the patients who underwent primary ACL reconstruction from January 2019 to November 2022 in a district general teaching hospital (DGH). Besides demographic data of the patients, we recorded the dates of injury, primary presentation, first knee specialist review, knee MRI, and ACL reconstruction surgery, as well as the injury-to-surgery, injury-to-MRI, and MRI-to-surgery periods. Patients were divided based on the date of operation to pre- and post-COVID, and outcomes were compared to see the possible effects of COVID-19. Data were analyzed using a quantitative and qualitative test with a P < 0.05 significance level. Results Our cohort included 97 patients, and the mean age of patients was 30.6 years (17-53 years). The median time of injury-to-MRI was 46.5 days during the pre-COVID period, which decreased to 44 days in the post-COVID period (P = 0.596). The median time of injury-to-surgery was 287.5 days during the pre-COVID period, which increased to 289 days in the post-COVID period (P = 0.019). The median MRI-to-surgery duration was 200 days during the pre-COVID period, which increased to 225 days in the post-COVID period (P = 0.006). Around 35% of patients had an MRI prior to getting evaluated by a specialist. Conclusion The COVID-19 pandemic had a significant impact on the management of ACL injuries, with delays in elective knee clinics and surgery potentially leading to delays in the diagnosis and management of such injuries. However, our study showed that the delay from ACL injury to subsequent surgery actually reduced post-pandemic due to hospital-based acute knee pathway, which is particularly important in the context of associated meniscal injury that can worsen while patients wait for surgery.
- Open Access
- 30 August 2023
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 110 (Supplement)
958 A Study on Electronic Treatment Escalation Plan (TEP) Forms Completion and Compliance
Aim: Establishing a Treatment Escalation Plan (TEP) allows doctors to discuss and record patient preferences in advance, in addition to cardiopulmonary resuscitation (DNA-CPR), but also for various aspects of emergency care and treatment.This study examines the overall rates of TEP form completion, as well as completion within 48 hours of the patient's hospitalization, as observed in routine practise at a DGH. Method: This study was conducted utilising PDSA (Plan-Do-Study-Act) cycles and a cross-sectional methodology, auditing all adult in-patients admitted to the hospital for Orthopaedic surgery.The first cycle occurred in March 2022, followed by interventions in the form of an institutional algorithm, and the second cycle followed in November 2022. Results: In the first cycle, 69.5% of patients had a completed TEP form, with 47.8% filling one within 48 hours of admission.It took an average of 4.4 days to complete, with 3.2 overrides. Following intervention and discussion in departmental meetings, 88.2% of tasks were completed, with 35.2% ended within 48 hours. Average days rose to 3.7 days, and overrides fell to 1.3 times. A questionnaire developed for the juniors to ask them about their reasons for noncompliance, and it was realised that the majority of them were concerned about the legal ramifications, correspondence with the patient and family, and a small percentage were due to a lack of time. Conclusions: When juniors are fully informed of the technique to complete TEP forms, completion rates increase significantly. The process would be maintained under control by regular audits and training for rotating juniors.
- 30 August 2023
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 110 (Supplement)
Open Access958 A Study on Electronic Treatment Escalation Plan (TEP) Forms Completion and Compliance
Aim: Establishing a Treatment Escalation Plan (TEP) allows doctors to discuss and record patient preferences in advance, in addition to cardiopulmonary resuscitation (DNA-CPR), but also for various aspects of emergency care and treatment.This study examines the overall rates of TEP form completion, as well as completion within 48 hours of the patient's hospitalization, as observed in routine practise at a DGH. Method: This study was conducted utilising PDSA (Plan-Do-Study-Act) cycles and a cross-sectional methodology, auditing all adult in-patients admitted to the hospital for Orthopaedic surgery.The first cycle occurred in March 2022, followed by interventions in the form of an institutional algorithm, and the second cycle followed in November 2022. Results: In the first cycle, 69.5% of patients had a completed TEP form, with 47.8% filling one within 48 hours of admission.It took an average of 4.4 days to complete, with 3.2 overrides. Following intervention and discussion in departmental meetings, 88.2% of tasks were completed, with 35.2% ended within 48 hours. Average days rose to 3.7 days, and overrides fell to 1.3 times. A questionnaire developed for the juniors to ask them about their reasons for noncompliance, and it was realised that the majority of them were concerned about the legal ramifications, correspondence with the patient and family, and a small percentage were due to a lack of time. Conclusions: When juniors are fully informed of the technique to complete TEP forms, completion rates increase significantly. The process would be maintained under control by regular audits and training for rotating juniors.
- 1 August 2020
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 38, 124-128
A comparison of dietary intake between personnel of a gas processing company and a sample population of public employees from Mashhad
- 1 August 2020
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 38, 124-128
A comparison of dietary intake between personnel of a gas processing company and a sample population of public employees from Mashhad
- 18 July 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (1) , 336-350
Gastrointestinal and hepatic abnormalities in patients with confirmed COVID‐19: A systematic review and meta‐analysis
Although not common, gastrointestinal and liver symptoms have reportedly been the initial presentation of coronavirus disease‐2019 (COVID‐19) in a large group of patients. Therefore, knowing the frequency and characteristics of these manifestations of COVID‐19 is important for both clinicians and health policy makers. A systematic review and meta‐analysis of the available data on the gastrointestinal and liver manifestations of patients with COVID‐19 was performed. PubMed and Scopus databases and Google Scholar search engine were searched for published and unpublished preprint articles up to 10 April 2020. Original studies providing information on clinical digestive symptoms or biomarkers of liver function in patients with polymerase chain reaction confirmed diagnosis of COVID‐19 were included. After quality appraisal, data were extracted. Prevalence data from individual studies were pooled using a random‐effects model. Overall, 67 studies were included in this systematic review and meta‐analysis, comprising a pooled population of 13 251 patients with confirmed COVID‐19. The most common gastrointestinal symptoms were anorexia (10.2%, 95% confidence interval [CI] = 6.2%‐16.4%), diarrhea (8.4%, 95% CI = 6.2%‐11.2%), and nausea (5.7%, 95% CI = 3.7%‐8.6%), respectively. Decreased albumin levels (39.8%, 95% CI = 15.3%‐70.8%), increased aspartate aminotransferase (22.8%, 95% CI = 18.1%‐28.4%), and alanine aminotransferase (20.6%, 95% CI = 16.7%‐25.1%) were common hepatic findings. After adjusting for preexisting gastrointestinal (5.9%) and liver diseases (4.2%), the most common gastrointestinal findings were diarrhea (8.7%, 95% CI = 5.4%‐13.9%), anorexia (8.0%, 95% CI = 3.0%‐19.8%), and nausea (5.1%, 95% CI = 2.2%‐14.3%). Gastrointestinal and liver manifestations are not rare in patients with COVID‐19, but their prevalence might be affected by preexisting diseases. Diarrhea and mild liver abnormalities seem to be relatively common in COVID‐19, regardless of comorbidities
- 18 July 2020
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (1) , 336-350
Gastrointestinal and hepatic abnormalities in patients with confirmed COVID‐19: A systematic review and meta‐analysis
Although not common, gastrointestinal and liver symptoms have reportedly been the initial presentation of coronavirus disease‐2019 (COVID‐19) in a large group of patients. Therefore, knowing the frequency and characteristics of these manifestations of COVID‐19 is important for both clinicians and health policy makers. A systematic review and meta‐analysis of the available data on the gastrointestinal and liver manifestations of patients with COVID‐19 was performed. PubMed and Scopus databases and Google Scholar search engine were searched for published and unpublished preprint articles up to 10 April 2020. Original studies providing information on clinical digestive symptoms or biomarkers of liver function in patients with polymerase chain reaction confirmed diagnosis of COVID‐19 were included. After quality appraisal, data were extracted. Prevalence data from individual studies were pooled using a random‐effects model. Overall, 67 studies were included in this systematic review and meta‐analysis, comprising a pooled population of 13 251 patients with confirmed COVID‐19. The most common gastrointestinal symptoms were anorexia (10.2%, 95% confidence interval [CI] = 6.2%‐16.4%), diarrhea (8.4%, 95% CI = 6.2%‐11.2%), and nausea (5.7%, 95% CI = 3.7%‐8.6%), respectively. Decreased albumin levels (39.8%, 95% CI = 15.3%‐70.8%), increased aspartate aminotransferase (22.8%, 95% CI = 18.1%‐28.4%), and alanine aminotransferase (20.6%, 95% CI = 16.7%‐25.1%) were common hepatic findings. After adjusting for preexisting gastrointestinal (5.9%) and liver diseases (4.2%), the most common gastrointestinal findings were diarrhea (8.7%, 95% CI = 5.4%‐13.9%), anorexia (8.0%, 95% CI = 3.0%‐19.8%), and nausea (5.1%, 95% CI = 2.2%‐14.3%). Gastrointestinal and liver manifestations are not rare in patients with COVID‐19, but their prevalence might be affected by preexisting diseases. Diarrhea and mild liver abnormalities seem to be relatively common in COVID‐19, regardless of comorbidities
- 1 March 2020
- Published by Elsevier in Journal of Transport & Health
- Vol. 16
Child injury mortality in Iran: A systematic review and meta-analysis
- 1 March 2020
- Published by Elsevier in Journal of Transport & Health
- Vol. 16
Child injury mortality in Iran: A systematic review and meta-analysis
- Open Access
- 7 February 2020
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 9 (1) , 1-10
“Infection prevention and control idea challenge” contest: a fresh view on medical education and problem solving
Healthcare-associated infections (HAIs) challenge modern medicine. Considering their high prevalence in Iran, we aimed to provide knowledge on the subject, and to teach about the importance of infection prevention and control (IPC) to a broad audience of pre-graduate healthcare professionals, focusing on education as the cornerstone of IPC. We invited Iranian medical students to present ideas on “how to reduce HAIs.” Projects were eligible if being original and addressing the call. Accepted projects were quality assessed using a scoring system. Forty-nine projects were submitted, of which 37 met the inclusion criteria. They had a mean score of 69.4 ± 18.3 out of the maximum possible score of 115. Four reviewers assessed the 37 projects for clinical applicability, impact on patient safety, and innovation, and selected the best 12 to compete at the 2nd International Congress on Prevention Strategies for Healthcare-associated Infections, Mashhad, Iran, 2018. The competition took place in three rounds. The selected teams presented their projects in the first round and debated one by one in a knockout manner, while the jury reviewed their scientific content and presentation skills. In the second round, the top 5 projects competed for reaching the final stage, in which the teams presented their ideas in front of a panel of international IPC experts to determine the first three ranks. At the end of the contest, the participants gained valuable criticisms on how to improve their ideas. Moreover, by its motivating atmosphere, the contest created an excellent opportunity to promote IPC in medical schools. Using innovation contests in pre-graduates is an innovative education strategy. It sensitizes medical students to the challenges of IPC and antimicrobial resistance and drives them to think about solutions. By presenting and defending their innovations, they deepen their understanding on the topic and generate knowledge transfer in both ways, from students to teachers and vice versa.
- 7 February 2020
- Published by Springer Nature in Antimicrobial Resistance & Infection Control
- Vol. 9 (1) , 1-10
Open Access“Infection prevention and control idea challenge” contest: a fresh view on medical education and problem solving
Healthcare-associated infections (HAIs) challenge modern medicine. Considering their high prevalence in Iran, we aimed to provide knowledge on the subject, and to teach about the importance of infection prevention and control (IPC) to a broad audience of pre-graduate healthcare professionals, focusing on education as the cornerstone of IPC. We invited Iranian medical students to present ideas on “how to reduce HAIs.” Projects were eligible if being original and addressing the call. Accepted projects were quality assessed using a scoring system. Forty-nine projects were submitted, of which 37 met the inclusion criteria. They had a mean score of 69.4 ± 18.3 out of the maximum possible score of 115. Four reviewers assessed the 37 projects for clinical applicability, impact on patient safety, and innovation, and selected the best 12 to compete at the 2nd International Congress on Prevention Strategies for Healthcare-associated Infections, Mashhad, Iran, 2018. The competition took place in three rounds. The selected teams presented their projects in the first round and debated one by one in a knockout manner, while the jury reviewed their scientific content and presentation skills. In the second round, the top 5 projects competed for reaching the final stage, in which the teams presented their ideas in front of a panel of international IPC experts to determine the first three ranks. At the end of the contest, the participants gained valuable criticisms on how to improve their ideas. Moreover, by its motivating atmosphere, the contest created an excellent opportunity to promote IPC in medical schools. Using innovation contests in pre-graduates is an innovative education strategy. It sensitizes medical students to the challenges of IPC and antimicrobial resistance and drives them to think about solutions. By presenting and defending their innovations, they deepen their understanding on the topic and generate knowledge transfer in both ways, from students to teachers and vice versa.
- 9 December 2019
- Published by Wiley in Haemophilia
- Vol. 26 (1) , 142-150
Rhenium‐188 radiosynovectomy for chronic haemophilic synovitis: Evaluation of its safety and efficacy in haemophilic patients
Introduction: Radiocolloids labelled with less costly and more accessible radionuclides such as rhenium‐188 are of interest to developing countries compared with those labelled with rhenium‐186 and yttrium‐90.Aim: This study was aimed to evaluate the efficacy and safety of radiosynovectomy using rhenium‐188 in patients with chronic haemophilic synovitis and recurrent hemarthrosis.Methods: In this quasi‐experimental prospective study, 20 haemophilic patients were evaluated at preinjection, and at 1, 3, 6 and 12 months after injection. Magnetic resonance imaging (MRI) was done to measure synovial thickness and to calculate Denver score. Joint radiographs were taken to measure the Pettersson score. The Gilbert questionnaire, Functional Independence Score in Hemophilia (FISH) and visual analogue scale (VAS) for pain were completed, and the number of bleeding episodes and factor consumption were recorded at each follow‐up visit.Results: The number of bleeding episodes, the amount of factor consumption per month, VAS pain scores and synovial thickness decreased significantly over time (P < .05). Gilbert and FISH scores showed significant improvement (P < .001). However, Pettersson score and Denver score showed no significant changes after injection. Minor complications including temporary pain and swelling occurred in 20% of patients, and no major complication was observed after rhenium‐188 injection.Conclusion: Our results indicated high clinical impact, efficacy, safety and low invasion of rhenium‐188 in radiosynovectomy of haemophilic patients. Considering the availability and relatively low cost of rhenium‐188 in developing countries, this can be a good treatment option for haemophilic patients with recurrent hemarthrosis, particularly when the synovial hypertrophy is not massive yet.
- 9 December 2019
- Published by Wiley in Haemophilia
- Vol. 26 (1) , 142-150
Rhenium‐188 radiosynovectomy for chronic haemophilic synovitis: Evaluation of its safety and efficacy in haemophilic patients
Introduction: Radiocolloids labelled with less costly and more accessible radionuclides such as rhenium‐188 are of interest to developing countries compared with those labelled with rhenium‐186 and yttrium‐90.Aim: This study was aimed to evaluate the efficacy and safety of radiosynovectomy using rhenium‐188 in patients with chronic haemophilic synovitis and recurrent hemarthrosis.Methods: In this quasi‐experimental prospective study, 20 haemophilic patients were evaluated at preinjection, and at 1, 3, 6 and 12 months after injection. Magnetic resonance imaging (MRI) was done to measure synovial thickness and to calculate Denver score. Joint radiographs were taken to measure the Pettersson score. The Gilbert questionnaire, Functional Independence Score in Hemophilia (FISH) and visual analogue scale (VAS) for pain were completed, and the number of bleeding episodes and factor consumption were recorded at each follow‐up visit.Results: The number of bleeding episodes, the amount of factor consumption per month, VAS pain scores and synovial thickness decreased significantly over time (P < .05). Gilbert and FISH scores showed significant improvement (P < .001). However, Pettersson score and Denver score showed no significant changes after injection. Minor complications including temporary pain and swelling occurred in 20% of patients, and no major complication was observed after rhenium‐188 injection.Conclusion: Our results indicated high clinical impact, efficacy, safety and low invasion of rhenium‐188 in radiosynovectomy of haemophilic patients. Considering the availability and relatively low cost of rhenium‐188 in developing countries, this can be a good treatment option for haemophilic patients with recurrent hemarthrosis, particularly when the synovial hypertrophy is not massive yet.